The clinical expression and emergence of porcine circovirus 2.
about
Development and use of a multiplex real-time quantitative polymerase chain reaction assay for detection and differentiation of Porcine circovirus-2 genotypes 2a and 2b in an epidemiological survey.Current state of knowledge on porcine circovirus type 2-associated lesions.The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada.Detection and molecular characterization of porcine circovirus type 2 from piglets with porcine circovirus associated diseases in Colombia.Global gene expression profiling of myeloid immune cell subsets in response to in vitro challenge with porcine circovirus 2bAssessing PCV2 antibodies in field pigs vaccinated with different porcine circovirus 2 vaccines using two commercial ELISA systemsGenetic characterization of porcine circovirus 2 found in Malaysia.Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinically infected with porcine circovirus type 2.Detecting emerging diseases in farm animals through clinical observations.Antigenic Determinants of Possible Vaccine Escape by Porcine Circovirus Subtype 2b Viruses.The Adjuvant Activity of Epimedium Polysaccharide-Propolis Flavone Liposome on Enhancing Immune Responses to Inactivated Porcine Circovirus Vaccine in Mice.Reproduction in porcine circovirus type 2 (PCV2) seropositive gilts inseminated with PCV2b spiked semenThe emergence of a new strain of porcine circovirus-2 in Ontario and Quebec swine and its association with severe porcine circovirus associated disease--2004-2006.Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication.Complete nucleotide sequence of porcine circovirus 2 isolated from piglets in china.Genomic analysis of porcine circovirus type-2 isolates in Alberta pigs demonstrating clinical porcine circovirus associated disease (PCVAD).Age, gender and litter-related variation in T-lymphocyte cytokine production in young pigs.Silencing of natural interferon producing cell activation by porcine circovirus type 2 DNA.Two Subgroups of Porcine Circovirus 2 Appearing among Pigs in Southern China.Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration.Efficacy of parenteral vaccination against porcine circovirus type 2 (PCV2) in seropositive piglets.Porcine Circovirus Type 2-Associated Cerebellar Vasculitis in Postweaning Multisystemic Wasting Syndrome (PMWS)-Affected PigsCrystal Structure of the Dimerized N Terminus of Porcine Circovirus Type 2 Replicase Protein Reveals a Novel Antiviral Interface
P2860
Q30544026-1EC68286-6154-4865-A6F5-201E0B3CCCE7Q34280942-45B4F5CC-46CC-4085-B1CC-1743B5226558Q34682282-A79DBB02-BF2C-4E61-A760-9835D052B76CQ34813754-E45E96E7-08E8-47E2-9C05-BC77B5C09EB2Q35117906-6D7A2440-75E5-490C-BDCA-2521D3F7D320Q35199079-607BC7EB-1601-4DAE-8EEF-73F47D9E9811Q35248630-82FB50E2-BEF1-4383-889C-70D518B94AB5Q35271142-46DF0133-0002-4A9E-817D-DEE8B9D81FCCQ35801565-282F3677-D035-4046-B560-D37F2B9A7A12Q35997585-84DC89E7-71FC-4F41-B63A-8D3FBE30D7AEQ36285370-CEBB9B83-C478-4C26-8111-D8C283DDD1E4Q36431921-3150B54D-DD19-46CA-B39C-29F01AD3563AQ36575447-2EB3C796-DFD8-44C7-BFF1-85F94B4343D0Q37005696-4B4A59C1-D33D-4254-85C8-FF3D2F369DBEQ37025327-ECAB898C-9217-4204-A2D0-0DBC7228E9C8Q39955270-E39654B6-83DD-4352-BAFD-04020443767CQ40406140-CDF06884-66F5-470E-B81B-43BE716C910AQ40467647-9F065849-4356-48AA-86E4-75D361A138ACQ41915619-72170BC8-44E2-4032-B60F-02B31ECC1907Q42198915-289161F0-829C-4536-A799-57D52471D1B9Q42562770-2F529AAF-A1FB-44E6-9E07-FC084EA335BBQ57207454-FAF62E4C-A07E-452E-9008-5E2A9741AC64Q57753250-F650EA6A-5AA1-4082-A2E6-2B46E146050B
P2860
The clinical expression and emergence of porcine circovirus 2.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The clinical expression and emergence of porcine circovirus 2.
@ast
The clinical expression and emergence of porcine circovirus 2.
@en
type
label
The clinical expression and emergence of porcine circovirus 2.
@ast
The clinical expression and emergence of porcine circovirus 2.
@en
prefLabel
The clinical expression and emergence of porcine circovirus 2.
@ast
The clinical expression and emergence of porcine circovirus 2.
@en
P1476
The clinical expression and emergence of porcine circovirus 2.
@en
P2093
John C S Harding
P304
P356
10.1016/J.VETMIC.2003.10.013
P577
2004-02-01T00:00:00Z